LA
JAZZ icon

Lee Ainslie’s Jazz Pharmaceuticals JAZZ Stock Holding History

Lee Ainslie’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,187
Closed -$504K – 378
2024
Q1 		$504K Buy
+4,187
New +$513K 0.01% 218
2021
Q4 		– Sell
-10,120
Closed -$1.32M – 481
2021
Q3 		$1.32M Sell
10,120
-15,738
-61% -$2.38M 0.01% 235
2021
Q2 		$4.59M Buy
25,858
+7,329
+40% +$1.27M 0.04% 100
2021
Q1 		$3.05M Buy
18,529
+9,480
+105% +$1.56M 0.03% 107
2020
Q4 		$1.49M Buy
+9,049
New +$1.35M 0.02% 174
2019
Q2 		– Sell
-39,040
Closed -$5.58M – 316
2019
Q1 		$5.58M Buy
39,040
+1,590
+4% +$207K 0.07% 177
2018
Q4 		$4.64M Buy
37,450
+570
+2% +$84.6K 0.07% 194
2018
Q3 		$6.2M Sell
36,880
-5,030
-12% -$865K 0.08% 147
2018
Q2 		$7.22M Sell
41,910
-20,450
-33% -$3.34M 0.08% 129
2018
Q1 		$9.42M Buy
62,360
+18,820
+43% +$2.76M 0.12% 106
2017
Q4 		$5.86M Buy
43,540
+21,760
+100% +$3.02M 0.07% 140
2017
Q3 		$3.19M Buy
21,780
+6,090
+39% +$921K 0.04% 139
2017
Q2 		$2.44M Buy
15,690
+5,510
+54% +$843K 0.03% 112
2017
Q1 		$1.48M Sell
10,180
-2,060
-17% -$268K 0.02% 99
2016
Q4 		$1.33M Buy
12,240
+2,530
+26% +$282K 0.02% 91
2016
Q3 		$1.18M Buy
9,710
+1,500
+18% +$202K 0.01% 106
2016
Q2 		$1.16M Sell
8,210
-860
-9% -$127K 0.02% 107
2016
Q1 		$1.18M Buy
+9,070
New +$1.13M 0.02% 89

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Lee Ainslie's JAZZ Position: Q2 2024 in Review

Lee Ainslie sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2024, closing a stake of 4,187 shares — an estimated $504K sold.

Lee Ainslie first reported a position in JAZZ in Q1 2016 and held it in 18 quarters. The position peaked at $9.42M in Q1 2018. 456 funds tracked by Wall St. Rank hold JAZZ as of Q2 2024.

  • Lee Ainslie reported no remaining Jazz Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Lee Ainslie sold 4,187 Jazz Pharmaceuticals shares in Q2 2024, an estimated $504K.
  • Lee Ainslie first reported a position in Jazz Pharmaceuticals in Q1 2016 and held it in 18 quarters.
  • Lee Ainslie's Jazz Pharmaceuticals position peaked at $9.42M in Q1 2018.
  • 456 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2024.

Based on Maverick Capital's 13F filing for Q2 2024, filed 14 Aug 2024.